FUZHOU LINSHI EXCELLENT INDUSTRY&TRADE CO.,LTD – Trademark Portfolio

Entity Type: 99

FUZHOU LINSHI EXCELLENT INDUSTRY&TRADE CO.,LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include IKYOOR. The owner is based in Fuzhou.

Zone A-3183, 15/F

Comprehensive Building, Free Trade Zone

Fuzhou 350000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

IKYOOR
IKYOOR
Registered 2021

Trademark Classifications

FUZHOU LINSHI EXCELLENT INDUSTRY&TRADE CO.,LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does FUZHOU LINSHI EXCELLENT INDUSTRY&TRADE CO.,LTD have?

FUZHOU LINSHI EXCELLENT INDUSTRY&TRADE CO.,LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does FUZHOU LINSHI EXCELLENT INDUSTRY&TRADE CO.,LTD file in?

FUZHOU LINSHI EXCELLENT INDUSTRY&TRADE CO.,LTD files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are FUZHOU LINSHI EXCELLENT INDUSTRY&TRADE CO.,LTD's most well-known trademarks?

FUZHOU LINSHI EXCELLENT INDUSTRY&TRADE CO.,LTD's registered trademark portfolio includes well-known marks such as IKYOOR. These are among 1 currently registered trademark in the portfolio.

What is FUZHOU LINSHI EXCELLENT INDUSTRY&TRADE CO.,LTD's trademark registration success rate?

FUZHOU LINSHI EXCELLENT INDUSTRY&TRADE CO.,LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.